Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXICURE, INC. Director's Dealing 2019

Dec 23, 2019

34752_dirs_2019-12-23_b19db0ab-c6d4-480c-b3ea-14b939564ac7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXICURE, INC. (XCUR)
CIK: 0001698530
Period of Report: 2019-12-19

Reporting Person: Muralidhar Bali (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-19 Common Stock $0.0001 par value P 727000 $2.75 Acquired 6977000 Indirect

Footnotes

F1: The shares are held by Abingworth Bioventures VII LP ("Abingworth VII"). Abingworth Bioventures VII GP LP ("Abingworth GP") serves as the general partner of Abingworth VII. Abingworth General Partner VII LLP, serves as the general partner of Abingworth GP. Abingworth VII (acting by its general partner Abingworth GP, acting by its general partner Abingworth General Partner VII LLP) has delegated to Abingworth LLP ("ALLP"), all investment and dispositive power over the securities held by Abingworth VII. ALLP holds the reported securities indirectly through Abingworth VII. The reporting person is an employee of ALLP.

F2: The reporting person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.